Clear Therapeutics is using a novel technology to develop drugs that will prevent and treat degenerative diseases caused by abnormal protein aggregation, such as Alzheimer’s and Parkinson’s diseases. The unique approach used by Clear is to target the brain pathology by clearing the brain of the toxic protein aggregates that attack nerve cells and disrupt normal brain function.

Alzheimer’s and Parkinson’s diseases  affect millions of people worldwide. Due to the rapid aging of the population, these diseases are reaching epidemic proportions in the 21st century. A cure must be found!